Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for emergence agitation in pediatric laparoscopic surgery under ERAS
ChiCTR2200059581Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA) and postoperative pain (2 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: postoperative sedative agitation score and postoperative pain score. Started May 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200059581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200059581.